Orkambi now available to children aged between 6 and 11 with Cystic Fibrosis

The availability of the drug Orkambi has been extended to eligible children with Cystic Fibrosis aged between six and 11.

Orkambi now available to children aged between 6 and 11 with Cystic Fibrosis
Thu, 15 Mar, 2018 - 15:47

The availability of the drug Orkambi has been extended to eligible children with Cystic Fibrosis aged between six and 11.

This comes following EMA approval in January of this year.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Impact of latest HSE hiring freeze on patients not yet known, Fórsa says Impact of latest HSE hiring freeze on patients not yet known, Fórsa says
Domestic violance 1,000 domestic abuse reports made to gardaí every week last year
A male patient consults with a doctor about prostate cancer or some other disease. Prostate cancer screening can lead to men facing unnecessary treatment, study finds
CourtsHeathrowHealthCystic Fibrosis
<p>Linda Kelly, national secretary for health and social care professionals, also raised concerns that children’s access to services depends on staffing levels within their local team. File picture</p>

Even full staffing would not meet demand in children’s disability services, Fórsa says

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited